Trials / Withdrawn
WithdrawnNCT02028104
Stem Cell Therapy in Traumatic Brain Injury
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Traumatic Brain Injury
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 6 Months – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with Traumatic Brain Injury
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous bone marrow mononuclear cell transplantation | bone marrow derived mononuclear cells are administered intrathecally in traumatic brain injury patients |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2016-04-01
- Completion
- 2016-09-01
- First posted
- 2014-01-06
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02028104. Inclusion in this directory is not an endorsement.